The question addressed in this communication is based on two observations we made during investigations on a leukemic (MOLT-4) cell line and on different human neuroblastoma cell lines. On MOLT-4 cells, we observed that ascorbic acid (AA) was able to diminish the growth inhibitory effects of methotrexate (MTX). The biological effect of MTX is due to its capacity to inhibit dihydrofolate reductase (DHFR) thereby preventing the NADH-dependent reduction of dihydrofolate to tetrahydrofolate . Therefore, the first question is whether AA is able to reduce dihydrofolate in a direct of indirect way bypassing the DHFR reaction. In other experiments we investigated the influence of AA on catecholamine metabolism on human neuroblastoma cells. It is well known that AA is a cofactor of the dopamine-~-hydroxylase reaction which catalyzes the hydroxylation of dopamine to noradrenaline. Surprisingly, AA was also able to enhance the hydroxylation of tyrosine to DOPA (3,4-dihydroxyphenylalanine) . Since the conversion of tyrosine to DOPA is associated with the NADH-dependent reduction of dihydrobiopterin to tetrahydrobiopterin, the question is, once again, whether AA is able to reduce also this dihydropteridine. If the observed effects of AA are not only artifical reactions under cell culture conditions, important consequence could be drawn for clinical practice: ( 1) : Consumption of large amounts of AA which is often done by self-medication during chemotherapy in order to reduce therapy-associated side effects should be strictly avoided during MTX-therapy. (2) : There are some hints in the literature that AA could be helpful in early Parkinson disease allowing to postpone the start of DOPA therapy. This has been interpreted due to its anti-oxidative properties. However, based on the data presented, AA could also act by enhancing endogenous DOPA synthesis.
The Macrophages (M<I», a cell of Multiple Functions and the Probable Involvement of Neopterin in the Apoptotic Pathway
Bujack H
Munich
There is common belief, M<I> are our first line of immunedeknse. But they have many basic metabolic fuctions.
1. Their name is their first function: Every organ has its residential M<I>, which are adapted with their receptors and products to the special needs of their organ. They phagocytise apoptotic cells, cellular debris and the substrates of the normal tissue-turnover. Bacteria, tumorcells and xenobiotics are probably not their regular diet. Proteins are degraded in the cytosolic proteosome, but not completely. The produced peptides become exported into the endoplasmic reticulum and finally presented at the cell surface with MHC. We are used to think about foreign antigen-presentation only. But MHCs are constitutively occupied by autologous peptides.
The most wellknown residental M<I> are Kupflercells of the liver and alveolar M<I> of the lung. The last ones phagocytise surfactant, produced by pneumocyte II and more than 90% of the substrate become recycled. Therefore the first metabolic function is not only phagocytosis, but also degradation and recycling of the substrates.
M<I> under the command of lipids : When
Pteridines/ Vol. 9/~o . 3 M<I> are externally treated by HNE (=4-0H-2 ,3-nonenal=lipid peroxydation endproduct) mRNA tor transforming grO\nh-tactor [31 (TGF-I3l ) is upregulated. This grow factor is a chemoattractant tor fibroblasts and fibroblast-like cells. Then to-cells of the liver are known to express augmented procollagen type I gene, leading to increased deposition of extracellular matrix (Link between oxidative injury and fibrosclerosis. FASEB J 1997;
11: 851-857) . HNE is otherwise known to be a product and at the same time an inhibitor of cytochrome P-450 enzymes, providing a negative feedback regulation. The endogenously produced HNE seems to be responsible for TGF-production in M<I> and the normal amount of extracellular matrix (Peroxydative reactions of diversozymes. FASEB J 1969; 10: 428-434). Therefore the second function of M<I> seems to be the regulation of extracellular matrix under the command of lipid peroxydation endproducts. 3 . M<I> under the command of cytokines and lipids: Homeostasis of cells means equilibrium between proliferation and apoptosis (=programmed cell death). M<I> produce a huge number of growth factors and carrier proteins for vitamines and lipids to support growth of other cells. Apoptosis seems to depend mainly on an activation cascade of caspases (ICE=caspase 1) and on C2-ceramides, known to activate CAPP (=family member of PP 2A phophatases) and NF-kB on the way to apoptosis.
Treatment of M<I> with interferon-y switches them from anabolic to catabolic state. Intermediates of tryptophan degradation (kynurenine and quinolinic acid ) can be found besides [32-microglobulin and 7,8-dihydroneopterin triphosphate. The high energy binding is necessary for conversion to biopterin by PTPS. When energy is missing usually the following reaction does not take place and the previous metabolite is piling up. That exactly happens with neopterin and it is finally leaking from the cell (Neopterin, Wachter H et ai., 1992, S.47-48 ). Then neopterin has lost its destination: biopterin. Now the question is: has CAPP something to do with the loss of the phosphate groups? Then M<I> activation would stand for the switch of metabolism to the apoptotic pathway and neopterin -the marker for activation would be a marker for apoptosis. Not neopterin, NO is regarded to be the deadly product of "activated" M<I>. Kupfler cells-derived NO is known to kill hepatocytes and sinusoidal endothelial cells of the liver. The problem in human M<I> is that NO is bound to a carrier (thiols or GS) and will be delivered in that bound form to the cells destinated for apoptosis, regulating homeostasis by that way.
The three conclusions are ( 1 ) residental M <l> suppor+: the growth of their related cells, (2 ) they regulate extracellular matrix production and (3) they regulate cell homeostasis of their organs and neopterin will mark the switch from "lite to death" and being an indicator, that biopterin -the cofactor and nee deed activator for special cytochrome P-450 enzymes -is missing.
Mechanism of Iron-Mediated Regulation of iNOS Expression
Dlaska M, Weiss G Department of Internal Medicine, University Hospital, Innsbruck, Austria
We have previously provided evidence for the existence of an autoregulatory feedback mechanism which links maintenance of cellular iron homeostasis with optimum formation of nitric oxide (NO) for host defence. Just as NO is able to mo dulate cellular iron homeostasis by a posttranscriptional mechanism involving RNA/ protein interactions, so is the expression of the cytokine-inducible form of NO-synthase (iNOS ) transcriptionally regulated by iron. In order to elucidate this latter phenomenon we constructed deletion mutants of a CAT-plasmid containing the iNOS promoter. These plasmids were transfected into murine fibroblasts (NIH3T3) and murine macrophages (J774). When using the parent plasmid containing the whole iNOS promoter stimulation of cells with IFN-y/ LPS and iron resulted in reduced CAT activity as compared to IFN-y/ LPS treated cells, while addition of the iron chelator desferrioxamine enhanced CAT expression. By means of deletion construct analysis and in vitro DNaseI-footprinting we could identii)' an iron regulatory region between position -170 and -140 upstream of the promoter. Stimulation of cells with IFN -y/LPS resulted in induction of CATactivity/ protection of the promoter region in the footprint while both signals were reversed upon addition of iron and enhanced by desferrioxamine. This region contains binding motifs for NF-IL6, NF-kappaB and STATI-a. Electromobility shift and supershift assays provided evicence that the observed effects of iron perturbation are most likely due to alterations of NF-IL6 binding to a consensus DNA element. A double mutation in the NF-IL6 binding site abolished iron metaited regulation of a construct consisiting of the first 200 bp of the i~O S promoter while in contrast in the nati\'e construct iron mediated regulation as well as cytokine inducibilty were still present. Our results provide evidence that transcriptional regulation of iNOS by iron perturbation is greatly due to modulation of the binding affinities of NF-IL6 to the iNOS promoter region.
Serum Neopterin Concentrations in GBV -C/ HGV RNA Positive Patients with Hematological Diseases
Eder G, Pavlova B, Heinz R Department of Hepatology, Immuno AG; Ludwig Boltzmann Institute for Leukemia Research and Hematology, Vienna Austria
We recently described a high prevalence of serum GBV-C/HGV RNA in patients suffering from hematological diseases [1] . A correlation between administration of blood products such as erytllrocyte or platelet concentrates, chemotherapy as well as liver diseases and GBV -C infection could not be established. The prognostic significance in severe viral infections such as HIV of elevated neopterin levels as a marker of immune activation of macrophages was demonstrated [2] .
Aim of our study: to investigate if neopterin m ay be indicative of GBV-C infection. 36 patients with hematological diseases without underlying liver disorders were tested for neopterin.
GBV-C RNA was detected by PCR with nested primers of the 5 UTR and NS3 regions . Neopterin in serum was measured by a commercially available reagent kit with an upper reference limit of 10 nmol/I (competitive enzyme immunoassay; IBL, Hamburg).
Of the 36 patients studied 23 were GBV-C RNA positive and 13 GBV-C RNA negative. In 5 sera (tour GBV-C RNA positive and one GBV-C RNA negative samples) borderline values between 10 and 11 nmol/ml neopterin were detected and considered negative. 14 of 23 GBV-C RNA positive and 4 of the 13 of RNA GBV-C negative samples showed distinctly elevated neopterin values (range 14 nmol/I-Ill nmol/l ). In 5 of the 23 GBV-C RNA positive and in 8 of 13 GBV-C RNA negative samples neopterin concentrations below 10 nmol/ml were detected. Statistical evaluation using X2 test (5% confidence limit) showed a significant difference in the 1 sided test. A corre-lation between neopterin and liver enzymes (ALT, AST and GGT) showed no significance.
Neopterin seems to be indicative of infection with GBV-C/HGV. The false negative rate was 39% (9 out of 23) and false positive 31% (4 out of 13) assuming that the borderline results were negative .
( Nitric oxide synthases (NOS) catalyze the oxygenation of L-arginine to L-citrulline and nitric oxide (NO) or a related oxide of nitrogen [1] . For unknown reasons NOS also requires the ubiquitous cofactor (6R)-5,6,7 ,8-tetrahydro-L-biopterin (H4Bip) to obtain maximal activity [2, 3] . Reif et al. (abstract submitted for this conterence ) have shown that H4Bip functions non-catalytically by stabilizing NOS homodimers during catalysis. Moreover, previous binding studies suggest an additional allosteric role of H4Bip on the L-arginine binding domain since the affinity of NOS for the L-arginine-derived inhibitor [3H]-N-nitro-L-arginine (NNA) was increased . Similarly, the binding of L-arginine to NOS increased the affinity for [3H]-H 4 Bip [4] . However, these binding studies use catalytically inactive NOS under non-physiological conditions and it is unclear whether these interactions are relevant for active enzyme, i.e. during L-arginine turnover.
In the present study, we therefore investigated the possible binding site interactions between H 4Bip and L-arginine binding domains using catalytically active NOS-I, and measured the effects on enzyme associated pterin. NOS-I from porcine cerebellum was isolated and purified by DEAE ion exchange and ADP-sepharose affinity chromatography. Enzyme activity was determined as the formation of [3H]-L-citrulline from [3H]-L-arginine. Concentration-response curves were constructed to either L-arginine (0-100 mM) or H 4Bip (0-100 11M ); Km and EC;o ,·alues were determPteridines/ Vol. 9 /~o. 3 ined, respectively, by non-linear regression analysis. Increasing the H 4B ip concentration from 0 .1 to 3 .011M decreased the Km of L-arginine for NOS-I suggesting a positive allosteric influence of H 4 Bip. Similarly, increasing the L-arginine concentration from 0 .3 to 30 11M decreased the EC so for H4Bip revealing a dual interaction between both binding sites. We also measured the effect on enzyme-associated pterin by reversed phase HPLC analysis [5] . In agreement, the loss of enzyme-associated pterin was lowered by preincubation with L-arginine . Moreover, we studied the effects of the potent, competitive inhibitor of the NOS pterin binding site PHS-32. This antipterin selectively displaced 82±9% of NOS-associated H 4 Bip, an effect which was dose-dependendy inhibited by L-arginine (52 ± 6% at 100 mM L-arginine).
Taken together, our findings demonstrate a physiologically relevant dual allosteric interaction between exogenous and endogenous H4Bip and the L-arginine binding site of catalytically active NOS-I. Surprisingly, these effects were also mimicked by the respective site-specific antagonists as the Larginine inhibitor NNA did not antagonise the allosteric effect of L-arginine on enzyme-associated pterin but increased H4Bip affinity similar to L-arginine.
( Litde is known about the cerebrospinal fluid (CSF) viral load dynamics in asymptomatic human immunodeficiency virus (HIV) infected patients. For determination of CSF viral load vari-ations in the natural course of HIV infection, 15 HIV infected patients without antiretroviral treatment and without HIV-associated symptoms at the start of the study were followed for 20 to 68 (mean 37.5) months with repeatedly collected CSF and serum. The samples were stored at 70 D C until analysed with quantitative polymerase chain reaction (PCR) for quantitation of HIV RNA. The viral load was compared with laboratory signs of immune activation, measured as neopterin concentrations in CSF and serum.
During the course of infection the HIV RNA levels increased significantly in CSF from on average 3.08 to 3.51 log 10 copies RNA/ml (p < 0.01) . A significant positive correlation was found between CSF levels of HIV RNA and neopterin . rs=0 .54, p < 0.01), which increased from 13.6 to 19.6 nmol/l (p < 0,01). No significant changes of HIV RNA or neopterin levels were found in serum.
Although possibly not reflecting local CNS tissue levels of HIV RNA, CSF analyses of HIV R.. "-:A are the closest and most appropriate reachable method in ante mortem studies. Increased CSF levels of neopterin indicate a chronic immune stimulation within the CNS, which is probably involved in the pathogenesis of neurological HIV disease. The increasing levels of CSF HIV R..'JA during disease progression and the correlation between increasing CSF neopterin levels and viral load found in this study indicate that this intrathecal immune activation might be ascribed to an increase in CNS viral load. In the present study a significant correlation was found between CSF and serum levels of HIV RNA, but a significant increase in viral load over time was only found in CSF, not in serum. Our study adds support to the theory of a chronic intrathecal immune activation triggered by an increasd CNS viral load. Neutrophil granulocytes are the first line of defence against invading microorganisms such as bacteria and fungi. The production of reaction ox-\"gen species plays an important role in this process. Granulocytes release superoxide anion, which dismutates to m .. 'ygen and H 2 0 2 , from which the highly potent HOCL is generated in the myeloperoxidase (MPO) reaction. Considering the important role of HOCI for effective killing of microorganisms, it is surprising that most MPO-deficient persons do not suffer more from lifethreatening infections than persons with normal MPO-activity. Therefore we are interested in the compensatory mechanisms of MPO-deficient granulocytes. In vitro, human macrophages produce and release neopterin. Based on the observation that neopterin modulates the toxicity mediated by reactive oxygen species, we first investigated, whether granulocytes are able to produce neopterin at the same experimental conditions used for macrophages. Granulocytes and macrophages were stimulated with 100 IU/ml IFN-y, neopterin was determined in the supernatant. The results show that human normal and MPO-deficient granulocytes do not produce neopterin in vitro, whereas the neopterin-production of macrophages increased after stimulation as expected.
Luminol (mainly HOCl-dependent signals)-and lucigenin (mainly 02-dependent signals)-enhanced chemiluminescence measurements were undertaken to investigate the modulating efIect of neopterin and 7,8-dihydroneopterin on reactive oxygen species produced by stimulated granulocytes. The cells were preincubated with the pteridine-derivates and activated after addition of phorbol-myristate-acetate and opsonized zymosan. Neopterin enhanced slightly PMA induced luminol-signals, whereas 7,8-dihydroneopterin scavenged PMA-signals. Lucigenin-enhanced signals were increased under preincubation of granulocytes with neopterin and stimulation with PMA. A potent scavenger of lucigenin-enhanced CL was 7,8-dihydroneopterin after granulocyte-stimulation with opsonized zymosan . Effects of iron and iron-chelatorcomplexes on the chemilurninescent behaviour are currently under investigation. Folate pathways overlap with homocysteine metabolism as the methylgroup of 5-methyltetrahydrofolate is transferred to the thiolgroup of homocysteine (hey) by vitamin Bll dependant methionine synthase to form methionine. 5-Methyltetrahydrofolate is a metabolite of the transmethylation cycle, in which the hydroxymethylgroup of serine is transferred to tetrahydrofolate by pytidoxal phosphate dependant serine-hydrm.)'methyltransterase to form 5,10-methylenetetrahydrofolate. The latter is reduced to 5-methyltetrahydrofolate by NADPH/ FADH2 dependant methylenetetrahydrofolate reductase (MTHFR) .
In the 'activated methyl cycle' meti-lionine, the product of hcy methylation, reacts with ATP to give S-adenosylmethionine, which transiCrs the methylgroup to a variety of methylacceptors. By splitting off adenosine from the resulting S-adenosylhomocysteine, hcy is formed.
Hyperhomocysteinemia is the general term for disorders resulting from elevated hey levels. Beside nutritional inadequacy there are mainly three enzyme defects responsible for an accumulation of hcy in the body. The involved enzymes are methionine synthase, MTHFR, which delivers the cofactor for the prementioned enzyme, and cystathion-[3-synthase, a key enzyme of the transsulfuration pathway. According to total plasma hcy levels (tHcy) hyperhomocysteinemia is classified as follows: severe form (tHey> 100 nmol/ml), intemediate form (tHcy=31-100 nmol/ml) and moderate form (tHcy=16-31 nmol/ml). Hey levels below 16 nmol/ml are regarded as normal. While cystailiione-[3-synthase-and MTHFR-deficPteridines/ Vol. 9 /~o. 3 iency are quite rare (0.5 and 1% respectively), the prevalence of thermolabile MTHFR is rather high: 5 to 15% of the general population are inflicted. Thermolabile MTHFR has reduced catalytic power and results from a mutation in the enzymes gene.
The most common form of hyperhomocysteinemia mainly results in cardiovascular diseases (CVD), but also in neurological disorders. In most of the studies to investigate the reduction of hcy levels, half to 10 mg doses of folic acid/day were administered alone or in combination with B-vitamins. In summary the results of all studies have shown, that elevated hey levels are significantly reduced by administration of folic acid and that elevated hcy seems to be a pathogenic factor and not only a marker of increased risk of CVD. In all cases, where folic acid has been successfully used for lowering hey levels, the active metabolite was 5-methyltetrahydrotolate. The administration of 5-methyltetrahydrofOiate would be more effective in the treatment of hyperhomocysteinemia as the conversion of the precursor folic acid requires 4 enzymatic steps involving MTHFR, an enzyme, which is often not fully active. [6S,SJ-5-Methyltetrahydrofolic acid isn't commercially available, yet, but we are capable of providing it in this naturally occuring diastereomeric pure form and hope, that there will be good use made of this compound in the treatment of hyperhomocysteinemia in future studies.
Serum and Cystfluid Markers for Epithelial Ovarian Cancer
Haeger H, Swahn M, Hahlin M, Bengtsson A, Horvath G Department of Obsterics and Gynecology; Gynecologic Oncology; Anaesthesiology and Intensive Care Unit, Sahlgrenska University Hospital, Gbteborg, Sweden Malignant ovarian tumours give no early warning signals and are therefore detected in advanced stages. Ovarian cancer is the third most common cause of cancer deaths in women and the leading cause of cancer deaths in gynaecological malignancies. Tumour markers, i.e . Ca-125, in ovarian cancer has so far been used in women known to have ovarian cancer in order to evaluate chemotherapy effect and detect early therapeutic failure. In patients with asymptomatic cystic ovarian tumours it is important to discriminate between malignant ovarian tumours and benign persistant ovarian cysts to avoid a substantial number of women undergoing surgery that may not be necessary. New tumour markers in plasma and cyst fluid combined or alone, and an ultrasound evaluation of the cystic ovarian tumour could reduce the number of surgical interventions . Earlier pilot studies by our group showed increased plasma and cyst fluid levels of neopterin, interleukin-6 and complement products in patients with ovarian cancer compared to patients with benign ovarian tumours. This might indicate that neopterin, IL-6 and some complement products might be useful as tumour markers. The aim of the present study was to determine whether the complement system is activated in patients with cystic ovarian tumours and if there is a difference in activation between malignant and benign tumours.
In 65 patients with cystic ovarian tumours of unknown histology the complement products C 4d, factor Rb, C3a and C5b-9 were determined in plasma and cyst fluid by commercial available enzyme immunoassays. 31 epithelial ovarian cancer and 34 benign ovarian tumours were diagnosed. Tumour size and patients age did not differ significantly between the 1:\\'0 groups . C4d, an indicator of complement activation through the classical pathway, and factor Bb, and cystfluid in patients with ovarian cancer compared to patients with benign ovarian tumours. C3a, an anaphylatoxin, and C5b-9, the end-product in activation of the classical as well as the alternative pathways of complement, were both higher in plasma and cyst fluid in patients with malignant ovarian tumours compared to patients with ovarian cysts of benign origin.
The present study shows that the complement system is activated in a significantly higher grade in patients with malignant ovarian cystic tumours than in patients with benign ovarian cystic tumours. The results indicate activation of complement both through the classical as well as through the alternative pathway . All studied complement products were increased in plasma and cyst fluid in ovarian cancer patients compared to women with benign ovarian cysts indicating that C4d, b.ctor Bb, C3a and C5b-9 might be useful as tumour markers in the preoperative assessment of patients with persistent ovarian cystic tumours. The oxidative modification of low-density lipoprotein (LDL) within the artery wall is thought to be a key event in the formation of an atherosclerotic lesion . Oxidatively modified LDL has chemotactic properties on macrophages. The socalled scavenger receptor of macrophages mediates the uncontrolled uptake of modified LDL which finally leads to the formation of lipid laden foam cells, the cellular hallmark of atherosclerosis. Oxidation of LDL is a process initiated and driven by free radical reactions [1] . Agents that can accomplish this form of LDL modification include -beside others -copper ions and/or peroxynitrite [2] .
In previous studies, it could be demonstrated that neopterin and dihydroneopterin are able to modulate the effects of cytotoxic agents like e.g. peroxynitrite either by catalyzing the production of reactive intermediates or by acting chemically as an antioxidant/reductant. Activated macrophages are the source of neopterin derivatives as well as of the peroxynitrite-precursors nitric oxide and superoxide anion. That means, the simultaneous occurrence of those three components in vivo is not unlikely to happen. Thus, the question arises, what kind of influence could have neopterin and 7,8-dihydroneopterin on the peroxynitriteinduced LDL oxidation?
Earlier it was found that 7,8-dihydroneopterin itself increases in a dose-dependent manner ( 1-10 11M ) the lag time of copper-mediated LDL oxidation whereas neopterin has no effects.
In our experiments we added to LDL a combination of different concentrations of neopterin or dihydroneopterin (both 10-150 11M) with copper(II)-ions ( 50 11M ) (20I1M EDTA) and/or peroxynitrite (3-5000 11M) and observed the progress of LDL oxidation by measuring either the formation of conjugated dienes or the increased relative electrophoretic mobility (REM). We also examined the influence of pre-incubation (20 min ) of neopterin or dihYdroneopterin with LDL before adding the other substances.
In contrast to earlier data, we could detect slightly enhancing effects of neopterin on coppermediated LDL oxidation especially after pre-incubation. In a combination of neopterin and peroxynitrite neopterin seemed to have at first (i.e. < 1 h ) enhancing effects and later on (i.e. > 2 h ) scavenging effects on peroxynitrite-induced LDL oxidation. Very clear is the enhancing intluence of neopterin on the accelerating effects of peroxynitrite on copper-mediated LDL oxidation . The earlier results concerning the effects of 7,8 -dihydroneopterin could be confirmed: dihydroneopterin scavenges -especially after pre-incubation with LDL -in a dose-dependent manner the effects of copper-ions and those of peroxynitrite. An absolutely new observation was made in experiments investigating relative electrophoretic mobility, where dihydroneopterin at a concentration of 100 11M showed enhancing effects on copper-mediated LDL oxidation (especially without pre-incubation). At a concentration of 150 11M dihydroneopterin, the scavenging effects seemed to increase.
An explanation for such a behaviour might be that dihydroneopterin reduces copper(II)-ions to copper(I)-ions. Such reduction of copper and other molecules is well known to promote lipid peroxidation up to a critical reductant concentration beyond which inhibition of peroxidation often occurs. Dihydroneopterin might be one reason for the direct copper reduction by macrophages. Further investigations have to be done for more detailed statements. Anyhow, the results up to now support the findings that neopterin derivatives are capable of modulating radical-driven reactions. In the case of atherogenesis this could be of special relevance: the increased serum neopterin levels found in atherosclerosis might play an important role in affecting the cytotoxic potential of activated macrophages and therefore the progress of vessel damaging.
( Multiple Trauma is associated with increased concentrations of circulating intlammatory mediators. Thus, the stimulation of trauma-released acPteridines/ Vol. 9 /~o. 3 tivators of the intlammatory casade leads to fundamental alterations in the hematological and immunological system. Moreover, bleeding is the major reason tor anemia early after trauma, several days later most patients suffer from low hemoglobin without evidence for blood loss. Thus, we investigated possible mechanisms for trauma induced anemia, e.g. iron deficiency or EPO suppression due to inflammatory cytokines and neopterin. We investigated 17 multiple traumatized patients (ISS> 30). Blood was collected within 3 h after admission at the ICU, and on day 2,4,6 and 9 after the trauma. For statistical analyses, Friedman two-way analysis of variance followed by Wilcoxon signed rank test was used (level of significance p < 0 .05).
Serum EPO did not change during the study (median: day 1:24.8 U/I; day 9:36.6 U / I) . Initial low levels of Hb (median 109 gil) remained unaltered until day 9. Serum iron was significantly decreased at day 2 and only slowly recovered. No change of serum transferrin and ferritin was observed. Interleukin-l-receptor antagonist was always elevated above the upper reference limit. Interleukin-6 (median 901 pg/ ml ) as well as granulocyte colony stimulating factor (G-CSF; median: 405 pg/ml) peaked after admission and dropped thereafter. In contrast to the unchanged tumor necrosis factor-a, the soluble TNF receptor-I was significantly elevated at day 6 and 9. Neopterin was in the normal range at day 1 but showed a steady increase with maximal concentrations at day 9 (median: 23.5 nmol/l ).
Severe trauma induces a rapid and complex response of inflammatory mediators. Serum EPO was low throughout the study in comparison to the reduced Hb concentration. Thus it seems that trauma causes a state of inadequate EPO response to anemia which could be the result of complex interactions between EPO production, cytokine and neopterin release and iron metabolism . Pteridine derivatives are widely distributed in all living cells. Several pteridines with different structures were tested for their interaction with bacterial and microsomal cytochrome P450 and yielded type II inhibitory spectra. Increasing pteridine Loncentrations raised the amplitude of the binding spectrum suggesting a low spin conformation at the heme iron. The type I binding spectrum following incubation of the enzyme suspension with camphor is diminished after addition of all tested pteridines. Pre-incubation of the enzyme with the pteridine derivative prevents to a high degree the generation of the camphor-dependent type I spectrum. Competition and displacement of the camphor molecule at the heme iron is suggested, indicating a high affinity of the pteridine derivatives to the acti,'e center of cytochrome P450cam.
The finanLial support by the Austrian Research Funds "Zur Forderung der Wissenschaftlichen Forschung" , project P12366, is gratefully acknowledged. A cDNA library prepared from Interferon-y (IFN-y) treated human myelomonocytoma cells (THP-1) was screened for GTP cyclohydrolase, the first enzyme of tetrahydrobiopterin biosynthesis. One of the isolated clones not only encoded for GTP cyclohydrolase but contained a second reading frame encoding for a putative new protein ligated to the GTP cyclohydrolase cDNA via the EcoR linker used for preparation of the library. Employing the GCG PILEUP program, we found that the new protein belongs to the family of c-x-c chemokines and shares high simliarities with the 94 amino acid protein MIG (monokine induced by interferon-y) and the 98 amino acid protein IP-10 (interferon-y-inducible protein, 10 kDa) . Due to its close relationship to the mentioned chemokines and since the cDNA was isolated from interferon-y-treated monocytes we termed the new c-x-c chemokine MIG-I3.
MIG-beta, New
The 94 amino acid protein MIG-13 encoded on the isolated 1455 bp cDNA clone shows 38% identity with MIG and 32% identity with IP-10 when comparing the amino acid sequences. Identity with MIG is 38,7% and 44,5% with IP-10 when comparing the nucleotide sequences. As for IP-10 and MIG, the first 21 amino acids show the characteristics of a signal peptide of a secretory protein. The predicted molecular mass of the 94 amino acid protein is 10,4kDa, which was confirmed by in vitro transcription/translation in a coupled reticulocyte lysate system. Northern-Blot analyses of human myelomonocytoma cells (THP-1) stimulated for 6 hours with interferons (cx, 13 and y (20 Vlml, 100 Vlml, 500 Vlm l, 2500 V I ml each) revealed highest sensitivity for the induction of MIG-13 by interferon-y. MIG-13 was also found to be expressed in various human cell lines like colon adenocarcinoma cells (DLD-I), skin carcinoma cells (A-431), epidermoid carcinoma cells (ME-I80), liver carcinoma cells (HepG2), glioblastoma cells (U -138) and endothelial cells from the umbilical cord (HUVEC) upon stimulation with interferon-y (1250 U/ml)±LPS (1 g/ ml ) for 7 or 24 hours. Human bladder carcinoma cells (T24) express MIG-J3 even without stimulation, whereas the colon carcinoma cell line CaCo-2, chronic myelogenous leukemia cells (K-562), leukemic T-Iymphocytes (MOLT-4) and Burkitt lymphoma cells (NAMALVA) cannot be stimulated for MIG-J3 expression by the stimuli used here. In 33 patients with neurodegenerative diseases (13 patients with Alzheimer's disease, 20 patients with Huntington's disease ) and in 9 elderly controls ( 52-89 years) we compared serum (nmol/L) and urine neopterin (J.l.mol/mol creatinine) concentrations. In further 11 patients (6 Alzheimer's disease, 3 Huntington's disease), in addition cerebrospinal fluid (CSF) concentrations of neopterin was compared to serum and urine levels. A close correlation existed between urine and serum neopterin levels in Alzheimer's disease (rs=0.707, p=O.Ol) and in Huntington's disease (rs=0.627, p < 0.01), however, the urine neopterin concentrations appeared to be unproportionally higher in the patients with Huntington' s disease compared to the individual serum concentrations. So far there is no clear explanation for this observation. Females tended to present with higher neopterin concentrations than males, this was particularly true for urine neopterin levels (e .g. Alzheimer's disease: U=6.58, p=O.OI). Age was significantly associated with urine and serum neopterin levels, the correlations being stronger for serum neopterin levels (Alzheimer's disease: rs=0 .595, p < 0 .05; Huntington's disease: rs=0 .643, p < 0.01 ). When Pteridines/ Vol. 9 /~o. 3 taking serum creaumne levels into account and calculating the neopterin per creatinine quotient also for serum neopterin levels (as it was applied for urine neopterin levels ) the correlations between serum and urine neopterin levels became even stronger, and the correlation between age and serum neopterin per creatinine levels became weaker compared to absolute serum neopterin levels. However, still a significant association remained between serum neopterin levels and age, indicating that renal function alone did not account for the increase of serum neopterin levels with age.
Neopterin Concentrations in Cerebrospinal Fluid
Cerebrospinal fluid neopterin concentrations in the eleven separate patients were closely related to serum levels (rs=0.767, p < 0.05) but 11/11 specimen had lower neopterin concentrations in CSF than in serum. This observation argues against an overwhelming production of neopterin within the CSF in patients with Alzheimer's disease or Huntington' s disease, rather it seems that increased serum neopterin concentrations are produced from peripheral immune activation and possibly contributing to an increase of neopterin in the CSF via transport through the blood brain barrier. CSF neopterin concentrations also correlated to urinary neopterin levels, however, the correlation was less strong compared to serum levels.
Association Between Body mass and Neopterin
Ledochowski M Department of Internal Medicine, University of Innsbruck, Innsbruck, Austria Besides many other findings, insulin receptor resistance is found in many obese persons and is thought to play a pathogenetic role in the developement of obesity. As it has been shown that interleukines such as TNF-a play an important role in the development of insulin recepror resistance in persons with non insulin dependent diabetes mellitus it was the aim of this study whether immune stimulation by itself may playa role in the development of obesity. From 1150 patients who underwent a medical health check up body mass index (BMI), plasma neopterin levels and other routine parameters were examined. 365 patients were excluded due to high leucocyte count, low hemoglobin levels or elevate blood sedimentation rate. The remaining 785 patients underwent statistical analysis.
From the 785 volunteers, 235 (30%) were clas-sified as moderately overweigth with a BMI from 25-30 and 64 (8%) were classified as severely overweight with a BMI> 30. Thirty-one (4%) were classified as underweight with a BMI smaller than 19 and the remaining 455 (58%) individuals were classified as normal weight with a BMI greater than 19 and smaller than 25.
Moderately overweight subjects showed significantly higher plasma neopterin concentrations than normal weight people (P < 0.015). Serum neopterin was also significantly elevated in individuals with a blood glucose concentration higher than 100 mg/dl (p < 0.00001) and HbAl-levels higher than 6 mg/ dl than in individuals 'with normal blood glucose levels and normal HbAllevels. There was a moderate but highly significant correlation between neopterin levels and age (r=0.3, p < 0.0001) and BMI and age (r=0.29, P<O.OOOl). The data shows that BMI and neopterin levels increase with age . Neopterin levels are also higher in individuals with elevated blood glucose and/or HbAl-concentrations. These findings suggest that immune stimulation may play a role in the development of obesity by inducing insulin receptor resistance via TNF-u. The levels of kynurenine in blood serum before and after L-tryprophan load in an oral dose of 30 mg/kg of body weight as well as the amounts of neopterin have been determined in 10 healthy subjects and 29 mesangioproliferative glomerulonephritis patients with proteinuria less than 2 g/ 24 h. We have found 4 versions of the changes of the metabolites in the serum. In 13% of patients we have found normal levels of both metabolites. In 13% we have found increased levels of kynurenine 3 hours after L-tryptophan load while in 46% there were increased levels of kynurenine before and 3-24 hours after L-tryptophan load. In 28% of patients there were increased amounts of kynurenine before and 24h after L-tryptophan load and also increased concentrations of neopterin. The elevated levels of kynurenine in the serum of mesangioproliferative glomerulonephritis patients with proteinura less than 2 g/24h could be caused by increased interferon-y activity of pyridoxal-5-phosphate deficiency in the organism, while the increased concentration of neopterin depends only on interferon-y activation. The L-tryptophan peroral loading test as well as neopterin determination can be useful for the differentiation of these both metabolic conditions in the pathogenesis of mesangioproliferative glomerulonephritis.
Human Parvovirus B19 Detection in Blood Donations: Correlations with Neopterin Levels Neopterin screening in blood donations has been mandatory in the Austrian Tyrol since October 1986 and is mandatory in the whole of Austria since 1994. The object of screening is to delete blood products of donors who obviously have had recent contact with viral antigens but do not feel sick at the time of donation and also pass the physical examination prior to donation. In earlier studies performed at our institute we have examined the presence of IgM antibodies in blood donations to: Cytomegalovirus, Parvovirus B19 and Ebstein-Barr-Virus. These studies have shown highly significant the benefit of screening for neopterin: IgM antibodies were found 3 to 5 fold more in the group of donors with elevated neopterin levels. Also seroconversions to Cytomegalovirus antibodies were observed and documented by serial bleedings in platelet donors. Another way to study the benefit of neopterin screening is to look at the presence of virus antigens. PCR technique has brought a powerful tool in testing for viral material even in low concentrations. After stimulation with cytokines, mainly interferon-y, cells of the monocytic celline accumulate large amounts of neopterin derivatives and produce only small amounts 5,6,7,8-tetrahydrobiopterin. This is caused by the rather low activity of the second enzyme involved in the synthesis of tetrahydrobiopterin: 6-pyruvolytetrahydropterin synthase (PTPS ).
A recent study about enzyme activity and mRNA levels of PTPS in human THP-l myelomonocytoma cells and fibroblasts showed a mRNA signal of THP-l cells on Northern blots comparable high to fibtoblasts, although the enzyme activity is much lower in THP-l cells.
To investigate PTPS mRNA a THP-l cDNA library of interferon-y treated cells was screened and found to contain two different types of PTPS mRNA: One with complete reading frame identical to PTPS mRNA isolated from human liver, and a mRNA missing exon 3. A PCR amplification using cDNA from interferon-y treated THP-l cells confirmed the two PTPS sequences, and a third typ missing exon 3 and 4 became evident.
The synthesis patterns of PTPS cDNA types isolated from THP-l cells were compared to PTPS cDNA patterns of macrophages and fibroblasts. It turned out that in THP-l cells, there is twice as much PTPS mRNA missing exon 3 than PTPS mRNA with complete reading frame and just very little of mRNA missing exon 3 and 4 . In contrast, fibroblasts mostly synthesise PTPS mRNA type with complete reading frame and small amounts of the type missing exon 3 and 4, but no mRNA missing exon 3. Amazingly, macrophages contain equal amounts of complete PTPS mRNA and mRNA missing exon 3 beside very little mRNA without exon 3 and 4.
These results demonstrate that PTPS mRNA of the investigated cell types is heterogenous, containing variable amounts of PTPS mRNA with complete reading frame and PTPS mRNA missing exon 3 . We suppose that RNA-splicing is a key to explain the low activity of PTPS in THP-l cells.
Kinetics of the Anti-cytomegalovirus Immune Response
Muller TF, Reschke M, Grebe SO, Lange H, Radsak K Department of Nephrology and Institute of Virology, Philipps-University of Marburg, Marburg, Germany Viral infections, in particular cytomegalovirus (CMV) diseases are a major complication in organ transplantation. Incidence and severity of the infections are directly related to the degree of immunosuppression. Especially the application of monoclonal and polyclonal antibodies is associated with acute CMV diseases. It could be shown that the TNF-o: release caused by antibody therapy leads to the reactivation of latent CMV infection \-ia the transcription factor NF-KB in an in vitro model using human CMV infected undifferentiated granulocyte/monocyte cell lines [1] . Neopterin is a :lurker of the cellular immune response: It is used .1S a diagnostic parameter for viral infections and J.iseases in organ transplantation.
In this study the time pattern of neopterin levds in patients with acute CMV diseases is in-\-estigated in relation to the application of monodonal and/or polyclonal antibodies.
Alltogether 49 renal transplant patients were induded in this retrospective study. The mean period of observation was 25 days (total of 1229 days), starting on the day of transplantation. The tollowing parameters were measured daily: neopterin in serum and urine (RIAcid, BrahmsOl:, Berlin), serum amyloid A (SAA; immunenephelometry, Be hring® , Marburg), blood leucocytes (Leuco), transaminases (GOT and GPT), and body temperature . Once weekly pp65 antigen, PCR for DNA, and IgG/IgM titers for CMV were tested. In addition a newly developed Western Blot (PurEpiMarburg®) for different CMV epitopes was performed in stored plasma samples. This test detects qualitatively the IgM and IgG immune response against the epitopes pp65, pp150, gB, and gH of the CMV genome. In addition direct and indirect tests for the other herpes viruses (Ebstein Barr virus EBV, herpes simplex virus HSV 1 and 2, varizella zoster virus VZV, and herpes hominis virus 6 (HHV6) were performed. The laboratory detection of CMV was defined as CMV infection, the occurence of additional clinical signs were defined as CMV disease. All patients recei\-ed a basic immunosuppression of cyclosporine and steroids. High risk patients and those with delayed graft function were treated with polyclonal antibodies ATG (ATG FreseniusOl:, Bad Homburg, Germany) as induction therapy. In cases of steroid-resistant rejection episodes monoclonal antibodies OKT3 (OKT3 Orthoclone®, Cilag GmbH, Sulzbach, Germany) were given.
In 29 patients the cytokines tumor necrosis factor alpha (TNF-o:) in plasma and soluble interleukin-2 receptor (sIL-2R) in plasma and urine were measured following the application of OKT3 and ATG.
Alltogethe r 31 antibody therapies were performed in a total of 27 patients. CMV diseases occurred exclusively in patients who were treated with antibodies.
The administration of the antibodies caused a cytokine release. In comparison to stable graft function the mean levels of plasma TNF-o: (stable US vs. OKT3 343 and ATG U8 pg/ml, resp.), plasma sIL-2R (stable 3188 vs. OKT3 4888 and ATG 4768 U/I, resp .), and urine sIL-2R (stable 823 vs. OKT3 1703 and 844 U/I, resp.) obtained during the first three days of antibody application were significantly elevated. In correspondance to these findings other markers like Temp, SAA, and serum and urine neopterin were elevated, in particular during the first doses of OKT3 .
A cumulative analysis of the time course in the neopterin values during the application of the antibodies in all 27 patients synchronized for the first day of antibody application showed after an early 3 day period of neopterin increase a fall and stabilization in the mean neopterin levels. However after 10 to 14 days a second increase in the mean neopterin values occurred.
In 6 patients (3 patients treated with ATG, 2 with OKT3, 1 with both antibodies) an acute CMV disease was diagnosed, in the mean on the 26th postoperative day. In all of these patients the urine and serum neopterin levels increased with values well above the threshold of 1000 and 500 J.!mol/mol creatmme, respectively. Concerning the kinetics of the CMV induced immune response the neopterin increases surpassing the defined threshold occurred in the mean on day 21 (± 2.5 ) following the start of antibody therapy.
The use of monoclonal and polyclonal anti -T cell antibodies causes an initial immune activation associated with a marked increase in neopterin and other mediator levels. CMV diseases induced by this combined activation and suppression of the immune system can be detected by daily neopterin monitoring. Concerning the temporal pattern of the cellular immune response in patients with CMV diseases a marked neopterin increase occurs about 3 weeks after starting the antibody therapy. In various malignant disorders, such as multiple myeloma, ovarian cancer, cervix carcinoma, prostate cancer, hepatocellular cancer, colon cancer or lung cancer high neopterin concentrations in serum and urine have been described to be associated with poor survival of patients . In this study, concentrations of neopterin, which is produced by human monocytes/ macrophages upon stimulation by interferon-y, were measured in urine specimens in 23 patients with squamous cell carcinoma of the oral cavity at the moment of diagnosis and in 12 treated patients with the same disease at the moment of the recurrence of the tumour. Tumour histology and routine laboratory parameters were concomitantly determined. Urinary neopterin values showed no statistically significant correlation with tumor differentiation, tumor size or patients' age, but they were significantly higher in patients with a recurrent tumor (p=0.025 ). Patients were followed up 4 years, and the ability of all variables to predict fatal outcome was assessed. In univariate analysis, only neopterin (p=O.Ol) and the variable recurrent versus first-diagnosed tumor (p=0 .005) were significant predictors of survival. By multivariate analysis, a combination of neopterin (p < 0.01 ) and the variable recurrent versus first-diagnosed tumour (P= 0.06) was found to jointly predict survival. Thus, urinary neopterin concentrations provide valuable prognostic information in patients with squamous cell carcinoma of the oral cavity.
The explanation for the predictive power of elevated neopterin in patients with malignancies is still a point of discussion: On the one hand elevations of neopterin, which is not a tumor marker in the usual sense of the word, indicate a chronic Pteridines/ Vol. 9 / No. 3 cellular immune response in patients. Thus, one might speculate that in these patients recognition of tumor cells by, and early activation mechanisms of, the immune system are intact, but effector functions are ineffective and appear to be severely suppressed. On the other hand, neopterin and 7,8-dihydroneopterin, a reduced neopterin derivative, have been shown to significantly enhance c-fos gene expression in rat NIH"T 3 fibroblasts in vitro. Thus, the compounds may even promote tumor growth and development. Therefore, the prognostic value of higher neopterin concentrations to predict disease progression and death in malignant diseases could be related to the capacity of neopterin derivatives to induce oncogene expression.
Reconstitution of the Oxidative Stress-Mediated Activation of Iron-Regulatory Protein-l in a Cell-Free System Pantopoulos K Gene Expression Programe, European Moleculabiology Laboratories, Heidelberg, Germany Iron regulatory protein-1 (IRP-1), a central cytoplasmic post-transcriptional regulator of cellular iron metabolism, is rapidly activated by oxidative stress to bind to mRNA iron-responsive elements (IREs) . We have reconstituted the response of IRP-1 to extracellular H Z 0 2 in a system derived from murine B6 fibroblasts permeabilized with streptolysin-O (SLO). This procedure allows to separate the cytosol from the remainder of the cells (cell pellet). IRP-1 in the cytosolic fraction fails to be directly activated by addition of H 2 0 Z ' IRP-1 activation requires the presence of a nonsoluble, possibly membrane-associated component in the cell pellet. The SLO-based in vitro system faithfully recapitulates characteristic hallmarks of IRP-1 activation by H 2 0 2 in intact cells . We show that the H20z-mediated activation of IRP-1 is temperatur-dependent and sensitive to treatment with calf intestinal alkaline phosphatase. While IRP -1 activation is unaffected by addition of excess ATP and GTP, it is negatively affected by the non-hydrolyzable nucleotide analogs AMP-PNP and GMP-PNP and completely blocked by ATPgS GTP-gsS. The in vitro reconstitution of this oxidative stress-induced pathway has opened a new avenue for the biochemical dissection of the regulation of mammalian iron metabolism by oxidative stress. Our data show that H 2 0 2 must be sensed to stimulate a pathway to activate IRP-1.
Blockage of Cranial Ganglions by Local
The superior cervical ganglion (Ganglion supremum) is the most cranial ganglion of the sympathetical trunk. It is situated beside the transverse processus of C2-C4, dorsal to the internal carotid artery, ventrolateral to the vagal nerve and medical to the jugular vein. The ganglion has various nerval interactions, e.g. with N. hypoglossus and N. accessorius, Ggl. interior nervi glossopharyngei et nervi vagi via N. jugularis, Plexus pharyngeus via rami laryngopharyngei and with epiphysis, hypothalamus and hypophysis via sympathetical fibres. Blockage of superior cervical ganglion by anestetic agents has various effects, e. g. a proven influence on the reticuloendothelial system via hypothalamo-hypophyseal complex, and on the melatonine metabolism, respectively.
In a prospective study 46 patients (25 male, 21 female, average age 47 years) received a therapy of repeated local blockages of the superior cervical ganglion by injections with 0.5% procaine. The duration of the treatment was 4 weeks with two injections every week. All injections were performed by one experienced person. Patients receiving that therapy suffered from tinnitus (n=20), polvarthralgia (n=O), chronic fatigue syndrome (n= 5), chronic headache (n=3) and miscellaneous diseases (chronic sinusitis, trigeminal neuralgia, postclimacteric syndrome). Pain was evaluated by using the visual rating scale (VRS) before the 1st injection and one week after the 8th injection. To check a possible influence on the immune response the following immunological parameters were determined in serum: neopterin, TNF-alpha, IL-l~, IL-6, IL-8 and IL-2-receptor. All determinations were performed before the 1st injection, after the 8th injection (end of therapy) and one week after the 8th injection. Statistical analysis were performed by Wilcoxon test. Patients suffering from rheumatoid arthritis, significant allergies and infectious diseases 14 days before therapy were excluded from the study.
Pain relief evaluated by VRS was significant after the end of the therapy. But the determinations of the immunological parameters showed no significant differences before and after repeated blockages of the superior cervical ganglion. Therapeutical blockage of superior cervical ganglion by local anesthetic agents is a helpful therapy in several chronic diseases, e.g. tinnitus, chronic fatigue syndrome . Pain relief was significant. Except for a possible influence on IL-8 serum levels a significant systemic influence on immune response could not be detected yet. Despite its complex anatomy and function the foot is even today a neglected subject in orthopaedic science and in daily clinical orthopaedic examination as well. In a prospective study histories were taken from in-patients with chronic back disorders receiving conservative orthopaedic treatment. 40% of these patients suffered from foot complaints. After a precise clinical orthopaedic examination of the feet a pathological gait was detected in 63% of these patients, foot deformities (disorders of the arches, toe deformities) in 80%. In 77% a · treatment by correction of the footwear was indicated. Especially in orthopaedic rehabilitation a precise examination of the foot and treatment of foot disorders should be given more attention. Interferon-y (IFN-y) alone or in combination with other cytokines such as tumor necrosis factora (TNF-a) or IL-l, two endogenous pyrogens, leads to up-regulation of GTP cyclohydrolase I and nitric oxide (NO) synthase. As a result of their very low 6-pyruvoyl tetrahydropterin synthase activity, cytokine-stimulated human monocytcs and macrophages form high amounts of neopterin . Although this human cell type expresses cytokine-inducible NO synthase, the amount of protein is too small to produce nitrite in the micromolar range. In contrast, murine monocytes and macrophages form tetrahydrobiopterin, a cofactor for the parallely induced NO synthase . These cells release high levels of NO which can be detected as nitrite in the supernatant. In addition to cytokines, bacterial products like lipo-polysaccharide (LPS ) are potent stimulators of these pathways [1] .
Agents for parenteral use have to be screened for pyrogenic contamination which is usually done by testing the temperature rise in rabbits upon application of the substance . Since LPS and related compounds are a major source for pyrogenic contamination, the only so far accepted in vitro alternative to the animal test is the limulus amoebocyte lysate (LAL) test. A new generation of this test using chromogenic substrates is highly sensitive and easy to perform . However, this test is specific for LPS and related compounds and does not detect other pyrogens like e.g. toxins or cell-wall components from gram-positive bacteria. Further, the LAL test is sometimes difficult to perform in solutions containing high amounts of protein.
In an effort to develop an alternative in vitro method for testing for pyrogens and based on the above-mentioned connection of immune stimulation and formation of pteridines and nitrite, respectively, we used monocytic cell lines for monitoring a panel of bacterial pyrogens from gramnegative and grampositive bacteria. Cells (THP-l human myelomonocytoma cells, 1774A.l or R--\\V264 .7 murine macrophages) were treated \\'ith IF);' -y minus or plus serial dilutions of the test sample for 24 to 48 hours. Supernatants were collected and either neopterin (THP-l) or nitrite ' . J774A.l, RAW264.7) were detected by ELISA and the Griess reaction, respectively. A first series of experiments showed that such an assay can detect LPS with comparable sensitivity to a chromogenic LAL test but has the advantage of clearly detecting compounds from gram-positive bacteria [2] . Further, a similar test using THP-l cells and detecting production of tumor necrosis factora by ELISA showed the advantage of the use of monocytic cell lines over the LAL test in highly proteinous solutions [3] . Serum-free cell culture media (X-Vivo 20, Ultraculture, AIM-V) can substitute for FCS-containing media in this assay without loss of sensitivity. Supernatants from Staphylococcus aureus patient isolates strongly increased formation of neopterin and nitrite, respectively. This effect is mediated by a heat-stable protein of about 30 kD. These results indicate that the assay is sensitive not only when using purified pyrogens but also when applying crude supernatants from bacterial cultures.
( 1 Detailed studies on the tautomerism of amino-, hydroxy-and mercapto-pteridines have revealed that the predominant tautomeric forms in aqueous solutions are represented by the amino, oxodihydro (lactam) and thioxodihydro (thiolactam) functions which are thermodynamically more stable than the corresponding imminodihydro, lactim and thiol tautomers [1] . It is also important to note that the H -atom of a lac tam and thiolactam is always located at the adjacent ring-N -atom and never on any other distant position indicating that the amide functions is stabilized in itself strongly by resonance. The structure of pterin should therefore be written as 2-amino-3,4-dihydro-4-oxopteridine (1) and not in any other tautomeric form such as 2 or 3.
In special cases the tautomerism can be 111-fluenced by steric factors or additional stabilization effects such as intramolecular hydrogen bondings favouring lactim configurations.
Whereas 2,4,7 -trihydroxypteridine exists as 2,4, 7-(IH, 3H, 8H ) pteridinetrione (4 ) its 1,3-dimethyl derivative (5) tautomerizes in the pyrazine moiety completely into the 7-hydroxy form from steric reasons [2] . 7-Hydroxy-Iumazine-6-carboxylic acid (6) belongs to the second type in which the iminol form 1S favoured by a hydogen bonding effect [3] .
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Side-chains are also often prone to tautomerism accounting on ring-N-atoms as stabilizing centers.
Ethyl-( 1 ,3-dimethyllumazin-6-yl )-pyruvate (7) tautomerizes to the vinylogous lactam form (8 ) which is stabilized in this configuration by the resulting amide resonance . In an analogous manner are the physical properties of the orange coloured butterfly pigment erythropterin (9 ) [4] consistent with the proposed structure. An interesting case of tautomerism was discovered during structural studies of 2-amino-4-pentyloxy-6-benzolmethylpteridine (15) [6] . The IH-NMR spectrum in D 6 -DMSO indicated the presence of an equal mixture of the keto ( 15 ) and the corresponding vinylogous lactam form ( 16) but during HPLC investigations three separate peaks were detected and the related substances isolated by chromatographical separation. Their structures were assigned by spectroscopic means as (15), ( 16) and a third isomer ( 18 ) resulting from intramolecular addition of the enol form (17) to the 7,8-position. All three tautomers are converted in aqeous solution slowly into a mixture of ( 15) and ( 16) . This is rare case where three tautomers have been separated and isolated. Recent advances in both computer hardware and software have revolutionized the way in which electronic structure and related properties of medium-sized molecules such as pteridine derivatives can be computed quantum-chemically, and in which the results of such computations can be visualized.
The quantum chemical software program package GAUSSIAN 94 (Gaussian Inc., Carnegie, PA, USA) enables one to compute, with high quality, the wave function of a molecule and, hereot~ the total electron density, molecular orbitals, orbital densities, and the electrostatic potential at lattice points of a lattice surrounding the molecule .
We used a UNIX based version of this software package running on a Silicon Graphics Workstation Indigo 2 (Silicon Graphics, Vienna, Austria).
The properties thus evaluated can be visualized in a multitude of possibilities using program A VS EXPRESS (Advanced Visual Systems Inc., Walt-ham, MA, USA) which runs on a personal computer. The software permits drawing of, e.g., threedimensional surfaces showing a variable as a function of two other variables, isovalued surfaces and/ or isovalued contour diagrams in arbitrarily selected slice planes, and any combinations of these possibilities. Moreover, a host of graphical features such as color-coding of surfaces can be employed to enhance the information content of the graphical representations .
Application of these new techniques on different pteridine derivatives shows the dramatic consequences of altered chemical structures upon the electronic and electrostatic properties of these heterocycles, and hopefully will provide a firm basis for understanding of the fundamental chemical characteristics and in particular of bioche mical interactions of these compounds.
Tetrahydrobiopterin Stabilises NO Synthase Quaternary Structure and Reacts with a Catalysis Product but has no Catalytic Role
Reif A, Frohlich L, Frey A, Kotsonis P, Bommel H , Pfleiderer W, Schmidt HHHW Department of Pharmacology and Toxicology, University of Wiirzburg, Wurzburg; Faculty of Chemistry, University of Konstanz; Konstanz, Germany L-Arginine-derived NO is an important second messenger with diverse physiological and pathological functions . NO synthesis from L-arginine is catalysed by the family of NO synthases (NOS), which require for unknown reasons the ubiquitous mammalian cofactor (6R)-5,6,7,8-tetrahydro-L-biopterin (H4Bip) to obtain maximal activity. Pervious studies have reported that native NOS exists as a homodimer [1] , which is stabilised by H4Bip [2] , however in this latter study catalytically inactive enzyme was assayed under non-physiological conditions (i.e . low-temperature SDS/ PAGE). The aim of the present study was to examine the influence of H4Bip on dimer stability of purified recombinant human NOS-I under catalytically active conditions. Upon L-arginine turnover, we carried out size-exclusion chromatography to determine the monomer/dimer ratio of NOS and measured its pterin content as well as NOS and cytochrome c reducase activities. In addition, the influence of pterin-derived inhibitors (anti-pterins ) on the NOS-I structure and activity was investigated. The o mission of H4Bip led to a Pteridines/ \-ol. 9 /~() . 3 time-dependent monomerization of NOS-I during catalysis \yhereas addition of this cofactor stabilised the enzyme's quaternary structure. The time-course of catalvsis -as determined by measuring the conyersion of L-arginine to the NOS coproduct L-circulline -revealed that omission of H4Bip led to a dramatic decrease in activity after 4 min of catalysis , whereas in the presence of this cofactor the reaction remained linear and at Vmax for at least 15 min. This coincided with a timedependent monomer/dimer ratio shift of NOS-I du"ring turnover. Analysis of the fractionated eluent of a Superose-6 gel filtration column (elution buffer: 150 mM NaCl, 20 mM TEA and 5% ethylene glycol) revealed that the dimers (Stokes radius 7.59+0.01 nm ) were active both with respect to citrulline formation and cytochrome c reduction. In contrast, monomers (Stokes radius 6 .24+ 0.06 nm) failed to produce cirulline but were still able to reduce cytochrome c. The dimers contained enzyme-associated H 4 Bip, whereas almost no pterin was found in the monomers. Additionally, we tested H 4Bip-derived inhibitors, which we have categorised recently into two subgroups. Type-I anti-pterins ( 100 mM PHS-32 ) do not inhibit basal NOS activity (26 ± 0.1 % of control ) -measured in the absence of exogenous H 4Bip-but nearly completely displaced enzyme-associated pterin (82±9% of control). These compounds mimicked the eflects of H4Rip on dimer stability whereas type-II anti-pterins (100 mM PHS-72), which also abolish basal NOS activity, did not. Interestingly, enzyme-asssociated and exogenous total pterin decreased in a time-dependent manner during L-arginine-turnover while in the absence of NOS H 4Bip was stable for at least 30 minutes. Thus H4Bip appears to react with a NOS derived product to yet to be defined pterin species or breakdown product.
Taken together, these data argue strongly against a catalytic role of H 4Bip in NOS paralysis but rather suggest a structural and stabilising function.
( 1 ) Schmidt HHHW et al., Proc Natl Acad Sci (USA) 1991; 88 : 365-369 . Previous investigations have shown that neopterin and kynurenine elevated the incorporation of saturated fatty acids and decreased the incorporation of arachidonic acid into phospholipids. The cholesterol content increased in these samples. 5,6,7,8-Tetrahydrobiopterin, its precursors and 3-hydroxykynurenine decreased the incorporation of saturated tatty acids, but stimulated unsaturated, especially arachidonic acid incorporation into phospholipids. The cholesterol content increased in these samples. It is also well established that tetrahydrobiopterin is necessary for tryptophan conversion to 5-hydroxytryptophan. Thus, tetrahydrobiopterin initiates the formation of serotonin, which has several biological activities on various organ systems. Nevertheless, very often inverse relationships have been found. Hence, the aim of this study was to examine the influence of serotonin (2 and 20 nmoljg wet weight ), 5-hydroxyindoleacetic acid (20 nmoljg wet weight) and iproniasid -an inhibitor of monoamino-Oz-ox\Teductase, EC 1.4.3.4 activity -(10 nmoljg wet weight) on phospholipid biosynthesis in vitro as well as cholesterol and phospholipid content. We observed that both concentrations of serotonin as well as 5-hydroxyindoleacetic acid induced an increased incorporation of arachidonic acid. The cholesterol content increased, while phospholipid levels remained unchanged in samples. An inverse relationship was found after addition of serotonin together with iproniasid to incubation medium for phospholipid biosynthesis in vitro. Then both concentrations of serotonin induced a decrease of stearic and palmitic acid and an increase of oleic, linolenic and arachidonic (8,11,14,17) acid incorporation into phospholids. The cholesterol content decreased while phospholipids content increased in samples. The changes obtained after addition of iproniasid alone to incubation medium for phospholipid biosythesis in vitro was not statistically significant. It allows us to suggest that the effect of serotonin on lipid metabolism depends on the balance between serotonin formation and splitting to 5-hydroxyindoleacetic acid. Plasma HIV -1 RNA levels indicate the magnitude of HIV -1 replication and have been shown to be a strong predictor of disease progression to AIDS. Therapy with highly active antiretroviral drug combinations can suppress plasma HIV-l RNA levels to levels belmv the limit of detection. Several studies have shmvn that such a suppression of viral replication predict clinical benefit with reduction of morbidit\· and mortality. However, there seem to be patients who deteriorate clinically despite sustained levels of HIV-l-RNA below the limit of detection. The question arises whether levels of neopterin in serum or urine might help to identifY those patients, receiving highly active antiretroviral therapy who are at risk of disease progression despite HIV~ 1 RNA levels below the limit of detection.
A 47 years old homosexual man presented with several AIDS defining diseases in march 1995 . At that time his CD4+ T-cell count was 40 cells/f.lL and the urinary neopterin level was 2360 f..lmol/ mol creatinine. Subsequently he received antire~ troviral combination therapy (including indinavir since May 1996) and his HIV -1 RNA levels dropped from 4.17 log copies/mL shortly before the use of indinavir, to levels below the limit of detection and remained at this level now for more than 18 months. The CD4+ T ~cell count did not change significantly during the antiretroviral therapy and was 40 cells/f..lL in December 1997. Levels of urinary neopterin were decreased to 454 f..lmol/mol creatinine in June 1997 but never reached normal values. Since June 1997 immune activation, as measured by urinary neopterin concentration, increased again and in December 1997 the urinary neopterin level was 1761 f..lmol/ mol creatinine.
At that time the patient suffered from severe weight loss (8 kg, 13% of his body weight), candida esophagitis and severe polyradiculo/neuropathy. He showed severe anemia, requiring erythrocyte transfusions and was severely debilitated, reflected by a Karnovsky score of 30. His disseminated Kaposi's sarcoma showed complete remission. Overall, did this reflect progression of HIV in ~ fection? The patient underwent a thorough work up without obvious evidence of infection or tumor. Because the patient showed a strong immune activation we decided to give immunosuppressive agents to the patient. First, he received two cycles of intravenous immunoglobulines (400 mg/kg/ d for five days) four weeks apart. Second, after 6 weeks we added Hydroxyurea to the antiretroviral combination. The patient's condition improved continuously, he gained weight (9 kg), his anemia was stabilized without further transfusions and the Karnovsky score increased to 50-60. Three month later the patient' s CD4+ T-cell count was unchanged (48/f..lL), however urinary neopterin concentration decreased markedly to 652 f..lmol/mol creatinine and HIV~ 1 RNA remained below the limit of detection.
Sustained suppression of HIV viral load did not necessarily result in clinical benefit in our patient.
Pteridines/ Vol. 9 /~o. 3 Increased \e,-eis of neopterin might help to identifY those patients who are at risk for disease progression despite 10\\' HIV-l RNA levels.
Correlations Between Hepatitis C and Neopterin Levels in Blood Donations
In Austria serum neopterin measurement has been introduced in 1993 as an additional unspecific screening marker for the detection of viral infections in blood donations. In earlier studies it has been demonstrated in blood donors who had already passed the physical examination before donation and who already had donated blood that subclinical acute infections were more likely to be detectable serologically in donations with increased neopterin concentrations compared to donations with lower neopterin levels. This could be confirmed especially in CMV~, EBV~ and Parvovirus B19 infections. In this study we compared HCV status in blood donations with increased (> 10 nmol/I) and normal neopterin concentrations.
54,402 blood donations were investigated. Beside the other mandatory screening tests (HIV~l and -2 antibody ELISA, hepatitis B surface antigen ELISA, Treponema pallidum hemagglutinin assay, ALT) all donations were tested for serum neopterin (IMMUtest, BRAHMS~ Diagnostica, Berlin, Germany) and HCV antibodies (Ortho HCV 3.0 ELISA testsystem, Ortho Diagnostics, Neckargmund, Germany). HCV antibody positive results were confirmed by a recombinant immunoblot assay (Chiron RIBA HCV 3.0 SIA, Chiron Corporation, Emeryville, USA). RIBA positive and indeterminate samples were also tested by peR (Amplicor HCV monitor, Hoffmann La Roche AG, Grenzach Wyhlen, Germany).
328 donors were HCV antibody positive (0.6%), 39 out of them were RIBA positive (0.072% of all donations), and 21 out of them (0.035% of all donations) were reactive with PCR. Among the 4, 251 donations with increased neopterin values (> 10 nmol/I) were 58/328 HCV antibody positives, 8/39 RIBA positives and 7/21 HCV PCR pOSitiveS (Odds ratio=S.9, p < 0.001). Similarly, 7/58 HCV antibody positive donations with increased neopterin were PCR positive, this was true only for 14/ 270 HCV antibody positi\O e with normal neopterin (Odds ratio=2.5, p=0.052).
On the basis of these data we conclude that there is a significant association between increased neopterin concentrations and a positive PCR result among the HCV antibody positive donations. It is obvious that not only acute and symptomatic HCV infections are detected by increased serum neopterin values as could have been expected from earlier studies, but also the frequency of asymptomatic chronic HCV carriers with RNA positivity as a sign of infectiosity was approximately 6-fold higher in donors with increased neopterin levels compared to those with normal concentrations.
In the Austrian Tyrol neopterin screening has been performed since 1986, since that time approximately 50,000 blood donations have been collected and tested per year. Assuming an average prevalence of 0.03% for HCV RNA positive and thus infectious donations at least 15 blood units of infectious donors must have been provided tor transfusion. One can assume that 6/15 had increased neopterin levels and had been excluded from transfusion solely for this reason. This fact is of importance especially for the time before 1990 when HCV was not yet identified. Nowadays it is of less importance concerning HCV but the data prove that neopterin screening serves as an umbrella to reduce the risk of transmission of a broad spectrum of known and also of even still unidentified viruses by blood transfusion . The following preliminary results are part of a study evaluating different screening methods (including neopterin, CMV antibody ELISA sand PCR) for th eir reliability for the detection of perinatale C\l\T infections. In this study 414 mother/child couples were included. CMV serology (IgG/ IgM antibodies ) and neopterin were measured in the second trimester of pregnancy. Umbilical cord blood samples of the corresponding newborns were also tested for CMV IgG/ IgM antibodies and neopterin. Statistics were performed to find out correlations between neoptcrin values of the pregnants and in umbilical cord blood samples of the newborns and for associations between neopterin values and diseases of the ne\\"borns or problems during delivery.
Neopterin Levels of Mother-child Couples Including Term and Preterm Newborns
So far no acute CMV infection of the newborns could be detected. Neopterin values of the pregnants: mean \'alue: 7.39 (2.4-27.5 ), neopterin values of the umbilical cord blood of the newborns: 14.86 (2.2-36.4). Correlation coefficient between neopterin of the pregnant and their newborns: 0 .25, that means that there is no statistically significant correlation to be found. Among the newborns 379 healthy babies (16 twins and 9 triplets) were found. 65 newborns were sick or suffered from problems during delivery. The following correlations between neopterin values and diseases of the newborns could be tound: Healthy newborns: neopterin values: mean 14.63, sick newborns: mean 15.85, p=0.083 (Mann-Whitney U test ). That means that a statistically significant correlation between elevated neopterin levels and "sick"' newborns can be found . This could especially be observed in newborns who were injured by vacuum extraction or during section (p=0.068 ). No significant correlations between neopterin levels and other diseases (respiratory distress, sepsis, light for date, pre term newborns) of the newborns could be found so far, esp. due to the low case numbers .
Mean neopterin values of newborns are significantly higher than the values of their mothers or healthy blood donors. A reason may be the activation of the immune system during delivery. There is no correlation to be found between neopterin values of the pregnants (second trimester) and their newborns. Comparing our results with those of a previous study with determination of maternal neopterin levels within 3 hours of delivery which showed no differences to healthy adult blood donors we conclude that the high neopterin levels in the umbilical cord blood are produced by the immune system of the newborn. There are differences between the neopterin values of healthy and sick newborns. Especially perinatals who were injured during delivery show significantly higher neopterin values than healthy newborns. In our study we could not find diff-erences between singles and twins/triplets.
Discussion: There are only few data available concerning neopterin levels in umbilical cord blood of newborns (Gerstner et al.). Our preliminary results show that it may be worth to have an eye upon the neopterin levels of the perinatal to get additional data of the immune system during delivery.
Tetrahydrobiopterin -the key to Understand Nitric Oxide Biosynthesis and Regulation Schmidt HHHW, Zabel U Department of Pharmacology and Toxicology, J ulius-Maximilians-University, Wiirzburg, Germany Nitric oxide (NO ) is an unusual messenger molecule with pleiotropic effects both in signal transduction and cytotoxicity. It is synthesized from the amino acid L-arginine by specialized cytochrome P-450 enzymes, nitric oxide synthases (NOS). However, one of the main enigmas of NOS catalysis is the unknown, yet essential, role of the cofactor tetrahydrobiopterin (H 4 Bip) . H~Bip binds to the oxygenase domains of all ~OS isotorms, and is essential for all crude or purified NOS preparations to reach maximal activity . However, the role of H 4Bip in NOS catalysis seems to be fundamentally different from that in other H 4 Bip-utilizing enzymes. In aromatic amino acid hydroxylating systems, H4Bip is utilized as an electron donor that binds and transfers electrons onto molecular oxygen. In doing so, H4Bip is reduced to H 2 Bip, and recycled back to H 4Bip by specific reductases. In contrast, no consumption of H4Bip was determined during NOS catalysis, in that neither the appearance of free H2Bip nor recycling of H4Bip was observed. Likewise, H2Bip does not appear as an enzyme-bound intermediate, since we could not detect a H 2 Bip-containing NOS species using HPLC (unpublished). Secondly, NOS shows an enormous selectivity for H 4 Bip, in that it can not utilize the closely related 5-methyl-and 6,7-dimethyl-H 4 Bip analogs, and binds H4Bip much more stringent than aromatic amino acid hydroxylases do. Nevertheless, in contrast to other P-450 enzymes, all three NOS isoforms copurity with H4Bip in stoichiometries ranging from 0.03-0.5 mol H4Bip per NOS homodimer. This led to the hypothesis that basal NOS activity is correlated to endogenously bound H 4 Bip. However, a regression analysis comprising all a\·ailable data on NOS basal activity and H4Bip
Pteridines/ Yol. 9 / ~o. 3 content, reyealed no correlation between these parameters.
Several functions for H 4Bip were discussed in the past years. A redox function and direct involvement in electron flux, as in the aromatic amino acid hydroxylase systems, is unlikely (s. above). A rather indirect redox function, the protection of the active center from oxidative damage, has been discussed. There are now several lines of evidence that account for an allosteric function for H 4 Bip. H4Bip influences binding kinetics for arginine, and vice versa, and alters the spectral properties of the prosthetic heme. It has been concluded from these data that H 4Bip might bind in close vicinity to the heme and arginine binding sites, but, importantly, the exact H4Bip binding site is still unknown. Several studies connect H4Bip function with NOS homodimerization. The main dimerization site is located in the oxygenase domain, since this part retains the ability to dimerize in the absence of the reductase domain. However, nothing is known about the exact amino acid residues directly involved in dimer formation . H4Bip was shown to promote dimerization of iNOS monomers expressed in a H 4 Bip-deficient cell line, and to stabilize iN OS and nNOS dimers under partially denaturating conditions. However, native NOS purified from tissue sources is nearly entirely in the dimeric state, although its pterin saturation can be as low as 5%, indicating that H4Bip is not absolutely essential for dimerization. The first direct approach to unravel the H4Bip binding site utilized a novel class of NOS inhibitors structurally related to H 4 Bip, called anti-pterins. Photoaffinity labeling of NOS-I with a radioactive anti-pterin revealed a fragment between the heme and CaM binding sites (aa367-772) sufficient for anti-pterin binding. Clearly more work is required to elucidate the function of H4Bip in NOS catalysis, but it will be essential in order to understand NO biosynthesis and its regulation. Exhaustive endurance exercise is known to be associated \\"ith Cs .i_:""!~.i= ": ~Iterations in the immune system . T he : :-~:-~Ll n e and inflammatory responses are s in:L 2~ : ,. t.~ose observed during infection and mild trauma. The degree of the immune response after exercise depends on several factors, e.g. type and duration of exercise as well as ambient conditions (e.g. temperature). Moderate exercise is suggested to increase immune competence, whereas extreme physical exercise may lead to a state of immune deficiency. Immune responses due to extreme physical exercise is documented by immunomodulation, that occurs due to an altered composition of immunocompetent cells as well as due to cell activation . Central to the activation of the immune system is the release of several c~·tokines (TNF-a, IL-I, IL-6, soluble IL-2 receptor). Interestingly, changes in cytokine levels in plasma are mosdy subde and of short half life . During immunological activation macrophages release neopterin upon stimulation with IFN -y. Reports about exercise-induced changes in serum-neopterin are scarcely in the literature. Small, but significant elevated concentrations of neopterin were observed in 2 studies after a long distance run (20 km run and a 2.5 h running test, respectively). Neopterin remained increased for at least 24 h post-exercise. Recently we could demonstrate a rapid and sustained increase of neopterin after an ultra marathon run (67 km) and a bicycle race (260 km) both performed at moderate altitude (up to 2800 m a.s.!. ). Since neopterin was also elevated during and after a hiking tour, hypoxia per se could be a stimulus for the release of neopterin independent of the intensity of exercise. Systemic lupus erythematodes (SLE) is a chronic autoimmune disease characterized by flares, the cause of which is unknown. This study was conducted in order to investigate whether daily stressors ha\'C an impact on the course of SLE . The methodological problems of external \'alidity and process analysis in stress research led us to choose a single-case design.
The Impact of Stressful
A 40 year-old woman who has been suffering from SLE since 1979 was observed for 63 days. Daily incidents were identified in weekly interviews. Daily urinary neopterin concentrations served as the indicator of SLE and was measured by HPLC. We controlled intervening variables such as infections, cigarette use, alcohol consumption and sleep.
During the 63 days 59 incidents were identified. Of these incidents, II were rated as having "some" severity (19% ), eight "moderate" (14%) and none "marked". The neopterin time-series was described by using the (1,0,0) (I,O,O)-ARJ-MA-model. Cross-correlational analysis revealed that incidents rated as moderately stressful had a significandy positive impact on the neopterin course the following day (lag I: +.325) .
In conclusion, working under assumption that the neopterin concentration is an indicator of SLE activity we demonstrated in a single-case study that approximately 24 hours after the occurrence of a "moderate" incident subclinical SLE activity increased. From a heuristic point of view we therefore might assume that highly stressful life events or chronic difficulties have a severe Impact on the course of SLE in this patient. Autoimmune disorders like systemic lupus erythematosus (SLE) are long-lasting inflammatory disorders with chronic immune activation . Additionally, patients with SLE often suffer from severe depressive reactions. Depression has been shown to be associated with decreased tryptophan levels which may also be related to the grade of immune activation. During states of THI-type immune activation interferon-y activates indole amine (2,3)-dioxygenase (IDO) which degrades tryptophan to form N-formyl-kynurenine in a primary step. From this background, we were interested in the assoCiatIon of clinically observed depression or psychiatric disturbances in SLE patients with the grade of immune activation and tryptophan catabolism. We therefore measured serum concentrations of neopterin (by ELISA, BRAHMS Diagnostica, Berrlin, Germany), tryptophan and kynurenine (by HPLC) in 57 patients with SLE, and we calculated the kynurenine per tryptophan ratio as an estimate the activity of IDO . The analytical data were compared with the activity of SLE and with the grade of psychiatric disturbances . Statistical analysis was done by nonparametric Wilcoxon and Kruskal-Wallis test, correlatuions were analysed by Spearman's rank test.
Serum Neopterin and
Compared to healthy controls, SLE patients had significantly elevated neopterin concentrations (mean±S.D.: 12.3± 10.4 nmoljL), decreased tryptophan ceoncentrations (52 .8± 14.6 J..lmoljL) and increased kynurenine levels (2.80± 1.50 J..lmolj L). The knyurenine per tryptophan ratios were increased (55.6±36.6 mmoljmol). There were significant associations between the increase of neopterin and the degradation of tryptophan in patients: neopterin correlated strongly with kynurenine concentrations (rs=0.601, p<O.OOOl) and with the kynurenine per tryptophan ratio (rs=0.672, p < 0.0001).
Our preliminary data suggest that immune activation as indicated by increased neopterin concentrations is associated with an increased tryptophan catabolism in patients with SLE . These observations could represent a key -regarding the longterm outcome -for the high rate of psychiatric disturbances in patients with severe autoimmune disorders like in SLE. Immunology playing a possible role in the etiopathogenesis of major depression or at least, it has been demonstrated by numerous studies during the last years that depressive disorders are accompanied by alterations of immune response. Since most findings in these patients focus on alterations of cell-mediated immunity (CMI) it seems to be an appropriate method to use neopterin as a \\'Cll established marker of CMI activation to detect abnormalities in patients early. Besides, changes of tryptophan and kynurenine metabolism are also involved in immunologic processes, whereby tryptophan plays also an important role in neurotransmitter synthesis, as a precursor influencing the availability of serotonin. The amine hypothesis of affective disorders postulates a defficency of cerebral noradrenaline and serotonin in the pathogenesis of depressive illness. Therefore, it can be understood that immunologic alterations leading to activation of indoleamine-(2,3 )-dioxygenase and thus to an increased tryptophan catabolism which decreases serotonin availability, can be considered as pathogenetic hypothesis of depressive disorders.
10 patients suffering from major depression (according to DSM-IV criteria) admitted due to severe depressive symptoms were allocated into the present study. All patients had allready previous episodes of affective disorders. Concentrations of neopterin (by ELISA, BRAHMS, Berlin, Germany) tryptophan and kynurenine (by HPLC) were measured in serum on the first day of hospitalisation (day 0), after 7 days of antidepressant treatment (day 7) and on the day of discharge from hospital. In comparison to agematched controls neopterin values were found to be significantly higher (p < 0.05) but without significant changes during the treatment period. Kynurenine levels were also higher in depressive patients but the difference did not reach statistical significance. Tryptophan measurements presented significantly lower values for depressive patients compared to healthy probands (p < 0.05). Lower tryptophan levels were found during the whole observation period without significant statistical changes. The finding of high neopterin and kynurenine and low tryptophan concentrations in depressive patients presents some further evidence for immunologic activation being involved in a possible pathogenetic mechanism of major depression. Althaugh the malecular details of the regulation of NOS subtypes remain to be elucidated. the present knowledge allowed for therapeutic intervention in traumatic and septic contitions. Currently, the administration of NO, NO-donors as well as NOS inhibitors is intensively investigated.
Experimental Inhibition of NOS to Treat
We report on the experimental use of the nonspecific NO? inhibitor L-NNMA in septic baboons and hypavolemic rats and compare these data to' first experiences with 4-Amino tetrahydrobiopterin (4-ABH4)' a pseudo-selective inhibitor for iNOS in endotoxic rats. We also provide evidence for a clearly protective effect of 4-ABH4 with regard to' mortality after an 80% lethal endotaxin challenge .
It is considered a major drawback of L-NNMA to exhibit a narrow therapeutic window. This situation is aggravated by deleterious effects in case of overdosing. Our data indicate that 4-ABH4 has a therapeutic aptimum too, but increasing the dose tenfold has no harmful side-effects beyond abolishing the therapeutic impact.
We conclude that 4-ABH4 is a prO'mising approach to the treatment af hypatension.
Further research on the mode of inhibition will be as pivotal as the availability of the drug for further animal experiments. Interferon-gamma stimulates human macrophages to produce neopterin and regulates vascular smooth muscle proliferation. In addition, fibrinogen seems to stimulate the migration af smooth muscle cells from deeper layers af the vascular wall into the lesion as well as to' stimulate the proliferation in the area af the lesion. Ac; neopterin and fibrinogen seem to reflect similar influences on atherogenesis, especially on the growth of the lesians, it is plausible that neopterin correlates significantly with fibrinogen in our subjects.
Further, we found a significant correlation of fibrinagen versus fibrinagen difference (before and after H.E.L.P. therapy; r=0 .724, p < 0 .01). Thus, the higher fibrinogen before therapy the higher is the decrease after therapy.
After long-term treatment with H.E.L.P. (four patients, 3 with CHD and ane with PE, neopterin determined before the first up to the 9th respectively 12 th therapy, ) we observed a decrease of neopterin (in 2 patients the decrease was significant). In contrast, fibrinagen stayed stable or even increased. One might speculate that the decrease of neopterin invariably seen after langterm treatment reflects an improvement of the chronic immune stimulation and thus, indicate clinical benefit. To elucidate the impact of biopterin production, nitric oxide (NO) formation and local immune activation on the clinical course of cerebral malaria we investigated cerebrospinal fluid (CSF) from 130 children who presented with this condition. Biopterin levels were significantly lower in patients with deeper coma (p=0.02). CSF concentrations of NO were significantly higher in children who died as compared to survivors (p=0 .037) which was not true for macrophage activation markers, neopterin and sTNFR 75. Biopterin, neopterin and sTNFR 75 but not NO concentrations were significantly related to each other. Low biopterin levels in deep coma are compatible with an impaired local TH-1 response, but this observation could also be due to scavenging of radicals or to decreased neurotransmitter synthesis . Local production of NO, most likely by non immune mechanisms, may be detrimental in cerebral malaria while this appears not to be the case for local TH -1 mediated immune pathways.
Cerebrospinal Fluid Levels of

Inhibition of Nitric Oxide Synthases by the 4-Amino Analogue of Tetrahydrobiopterin
Werner ER, Schmidt K, Werner-Felmayer G, Mayer B Institute of Medical Chemistry and Biochemistry, Unversity of Innsbruck; Institute of Pharmakology and Toxikology, University of Graz, Graz, Austria
We have developed the 4-amino analogue of tetrahydrobiopterin to study a potential redox-active role of tetrahydrobiopterin in the NO synthase reaction (Werner ER et at., Biochem.J. 320: 193-6, 1996) . We found that this compound ef· ficiently bound to NO synthases and inhibited the stimulation of the enzyme activity by tetrahydrobiopterin without aftecting the basal activity observed in absence of added cofactor. Complete inhibition of NO synthases is tl1erefore achieved only when pterin free enzymes are contacted with the inhibitor. Despite of inhibiting the stimulation of the enzyme activity by tetrahydrobiopterin, the 4-amino analogue of tetrahydrobiopterin confers Pteridines/ Vol. 9 / No, 3 the known allosteric actions of tetrahydrobiopterin to NO synthases, i.e . support of dimerization, facilitation of low to high spin heme conversion and increase in substrate affinity. We concluded, therefore, that allosteric actions alone cannot fully explain the mechanism of stimulation of NO synthases by tetrahydrobiopterin (Mayer B et at., Biochemistry 36: 8422-8427, 1997; Pfeifter S et ai., Biochem J 328: 349-352,1997).
When tested in cytokine-treated murine fibroblasts, the 4-amino analogue of tetrahydrobiopterin is as active as N"-monomethyl-arginine in inhibiting the inducible isoform of NO synthase in these cells (IG;o=15 mM). In porcine endothelial cells, however, NO syntl1esis is inhibited only at 30-fold higher concentrations (IC so =420 mM), although recombinant bovine endothelial NO synthase is inhibited (IG;o=15 mM) with a potency comparable to recombinant murine inducible NO synthase. This surprisingly high selectivity of inhibition of the inducible isoform of NO synthase in cultured cells is best explained by the diftcrent half life of the proteins. Inducible NO synthase is synthesized and degraded quite rapidly (tl/ 2 -3 h), thus enabling the inhibitor to contact the newly synthesized protein. Endothelial NO synthase (e / 2 -20 h), in contrast, is already present when the inhibitor enters the cells. Since the 4-amino analogue of tetrahydrobiopterin is not toxic to cells and does almost not inhibit phenylalanine hydroxylase (IC so -1 mM), our data indicate that this compound may be well suited for preferential inhibition of the inducible isoform of NO synthase in vivo. The cytotoxic impact of endogenously produced nitric oxide (NO) can be partly ascribed to the formation of peroxynitrite (ONOO) which is a strong oxidizing agent. Peroxynitrite is rapidly formed in a non-enzymatic reaction from NO with superoxide anion (0 2 . -). The latter reactive oxygen species is primarily released by stimulated phagocytes. At physiological conditions, peroxynitrite is unstable, and its decomposition pro-ducts are presumed to be capable of destroying important biologic structures. At physiological pH, the nitrating assault of peroxynitrite or of intermediately formed N0 2 +, respectively, is maximum, leading to the nitration of essential molecules, e.g., residues of aromatic amino acids.
Influence of Neopterin
When the cellular immune system is stimulated by interferon-y, neopterin and 7,8-dihydroneopterin are released by human monocytes/macrophages in parallel to several reactive species. It is known that neopterin derivatives influence the effects of reactive metabolites, hence interactions of neopterin and 7,8-dihydroneopterin with the nitration potential of peroxynitrite seem reliable.
In an earlier study, peroxynitrite prepared externally was co-incubated with tyrosine. Neopterin enhanced the reaction at slightly acidic conditions, whereas dihydroneopterin strongly suppressed nitration. In order to study in more detail this kind of interaction, we examined the reaction at more stable conditions. We tested in vitro, if neopterin and 7,8-dihydroneopterin influence nitrotyrosine formation when peroxynitrite produced in situ is incubated with L-tyrosine for 24 h. By measuring formed nitrotyrosine via HPLC, an enhancing effect of 200 Ilmol/L neopterin could be observed between pH 4 and pH 5.5, suggesting a catalytic mechanism of neopterin. The promotion of the reaction rate was up to 70% referred to a control incubation in absence of neopterin. 7,8-Dihydroneopterin (200llmoljL) acted as strong scavenger which completely suppressed the nitration at any pH. Also the impact of other pteridines on the nitration of tyrosine was examined. Most of the oxidized forms, like monapterin, biopterin, or pterin carboxylic acid, had a more or less enhancing influence except xanthopterin which decreased nitrotyrosine formation by 40%.
Oxidized pteridines may increase the nitration of tyrosine by promotion of peroxynitrite cleavage, whereas the reduced forms, e.g., 7,8-dihydroneopterin, act as antioxidants, deactivating the involved reactive species. The results give further evidence that pteridine derivatives modulate the cytotoxic potential of peroxynitrite and that the balance of neopterin and 7,8-dihydroneopterin may be crucial for the cytotoxic mechanisms forced by peroxynitrite. Patients, recruited in the first year since protease inhibitors became available, were assessed for the efficacy of triple therapy consisting of zidovudine or stavudine and lamivudine and indina vir or ritonavir on plasma HIV RNA titer (Amplicor Roche), the CD4+ T-cell count and urinary neopterin. 77 patients were 6 months and 42 patients were 12 months on triple therapy. 63 of them were pretreated with nucleoside combination therapy, 59 had AIDS, 24 were female and 30 injecting drug users , 17 homosexual men. Methadon treatment was given on agreement with the patients on a daily, weekly or biweekly basis to individual patients directly at the AIDS Clinic.
Results are given in an Intent-to-treat analysis. At baseline median HIV RNA levels were log 5 .07 copies/mL, the median CD4+ T-cell count 101 / ilL and median urinary neopterin 588 Ilmol/mol creatinine. A median decrease of 1.68 log in plasma HIV RNA levels, 326 Ilmol/mol creatinine urinary neopterin and a median increase of 79 CD4+ T cells were observed between baseline and week 52 (all P<O .Ol ). The change in laboratory markers was stronger in injecting drug users than in homosexual men. HIV RNA levels dropped to levels below the limit of detection (200 copies/mL) in 43/77 (55.8%) at week 12 and in 23/42 (54.7%) at week 52, these patients had lower HIV RNA (p=0.02) and unnary neopterin levels (P=0.03 ) at baseline, whereas the CD4+ T-cell count did not differ. A normalization of urinary neopterin differs significantly between those who had HIV RNA levels below or above the limit of detection.
The observed changes in laboratory markers imply high efficacy of antiretroviral combination therapy. Frequent monitoring seems to be a prerequisite for triple therapy, particularly in injecting drug users. Less frequent monitoring of homosexPteridines/ Vol. 9 /~o. 3 ual men might have contributed to the lower efficacy o f tripl e therapy in this population. Normalization of urinary neopterin concentrations was associated with a high fi-equency of undetectable HIV RNA levels, therefore frequent monitoring with urinary neopterin seems to provide useful information on compliance and efficacy in a cost-eftective manner. In addition, antiretroviral therapy should be started before urinary neopterin levels increase above The prognostic value of endogenous cytokines supplied with deterministic properties in the generation of either T helper (Th) I-type or Th2-type immune response was evaluated in ovarian cancer. A crucial role in the differentiation of naive ThO cells towards Thl cells with a subsequent activation of the cellular immune system is attributed to IL-12. The major counterparts of IL-12 are IL-I0 and IL-4, which both exhibit suppressive activities on macrophage functions and favorize Th2 differentiation . These cytokines were measured in serum and ascitic fluid of 76 ovarian cancer patients (FIGO stage Ic-IV) by means of enzyme-immuno-metric assays together with other parameters involved in the activation of the immunological network, such as neopterin, IL-2R, M-CSF, TNF-a, TGF-I , TGF-2, soluble CD44 standard and its splice variants v5 and v6. Survival analyses were performed with the KaplanMeier method and differences in survival were examined according to Mantel and Breslow. Cox proportional hazards analysis was used to identif)' independent prognostic factors. In univariate analysis, disease free -and overall survival was found to be significantly shorter in patients with ascitic concentrations above the estimated median value of neopterin (p < 0.03 ), TNF-alpha (p < 0 .005) and ILl2 (p < 0.005). In the multivariate Cox regression in addition to FIGO stage (p < 0.0001) and residual disease (p<O .Ol ), ascitic IL-12 was the only of the herein determined "immunological factors" which retained independent significance in predicting both disease free-(p < 0.03) and overall survival (p < 0.01). None of the
